eli lilly & co (LLY:New York)
Executive Profile*
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President, Eli Lilly and Company |
Age | Total Calculated Compensation | This person is connected to 44 board members in 6 different organizations across 4 different industries. See Board Relationships |
58 | $16,370,094 As of Fiscal Year 2011 |
Background*
Dr. John C. Lechleiter, Ph.D., serves as the Chairman, President and Chief Executive Officer of Eli Lilly and Company. Dr. Lechleiter serves as Treasurer at Pharmaceutical Research and Manufacturers of America. He served as President and Chief Operating Officer of Lilly, beginning in 2005, when he joined the board. In 2004, he became Lilly’s Executive Vice President for pharmaceutical operations. Prior to that, he served as Executive Vice President for pharmaceutical ...
Corporate Headquarters*Lilly Corporate CenterIndianapolis, Indiana 46285 United States Phone: 317-276-2000 Fax: 317-276-3492 Board Members Memberships*Treasurer and Director Director Director 1999-N/A Former Director, Member of Audit Committee and Member of Compensation and Incentive Committee 2005-Present Chairman, Chief Executive Officer and President 2009-Present Independent Director, Member of Compensation Committee and Member of Corporate Responsibility Committee
Education*Doctorate Harvard University PhD 1980 Harvard University Master's Degree 1980 Harvard University BS 1975 Xavier University
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
Recently Viewed | |||
LLY:US | $49.55 USD | +0.30 |
COMPETITOR COMPENSATION
Name | Position/ Company | Compensation |
Robert A. Bradway | Chief Executive Officer, President, Chief Operating Officer and Director Amgen Inc. | $1.0M |
Lamberto Andreotti | Chief Executive Officer, Director, Member of Executive Committee and Member of Science & Technology Committee Bristol-Myers Squibb Company | $1.5M |
John C. Martin Ph.D. | Chairman of the Board and Chief Executive Officer Gilead Sciences Inc. | $1.4M |
Pascal Soriot | Chief Executive Officer and Executive Director AstraZeneca PLC | -- |
Yasuchika Hasegawa | Chief Executive Officer, President and Representative Director Takeda Pharmaceutical Company Limited | -- | Compensation as of Fiscal Year 2011. |
Post a JobJobs
- San Diego, CA | ELI LillyPosted: Dec 18
- Indianapolis, IN | ELI Lilly and CompanyPosted: Nov 21
- Indianapolis, IN | ELI LillyPosted: Dec 20
- Indianapolis, IN | ELI LillyPosted: Dec 20
Sponsored Links
To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.